There are a range of brain tumours that can occur in children. Correct diagnosis is essential to select the best treatment option, but it is not always easy for pathologists to accurately determine each tumour type. MNP2.0 offers molecular analysis of brain tumours to assist the traditional diagnostic techniques, and provides additional information regarding molecular classification, genetic changes and potential therapeutic targets. Samples of the brain tumour are shipped to Germany and the results provided to treating oncologists in Australia and New Zealand.
Disease Stage: Newly diagnosed
Patient Age Range: Up to 21 years
Recruitment Period: To late 2019
- International: DFKZ (German Cancer Research Centre)
- National: ANZCHOG